Telomerase-Activating Compounds for Environmental Sustainability and Human Health

Publication ID: 24-11857516_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Telomerase-Activating Compounds for Environmental Sustainability and Human Health,” Published Technical Disclosure No. 24-11857516_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857516_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,516.

Summary of the Inventive Concept

Expanding the application of telomerase-activating compounds to address pressing environmental and health concerns, including pollution, cognitive impairment, radiation damage, and neurodegenerative diseases.

Background and Problem Solved

The original patent focused on fertility and related applications, but the core technology has untapped potential in other areas. This new concept leverages the telomerase-activating compounds to tackle critical issues in environmental sustainability and human health, where current solutions are inadequate.

Detailed Description of the Inventive Concept

The inventive concept involves the use of telomerase-activating compounds in novel applications, including environmental pollution monitoring and control, cognitive function enhancement, radiation protection, healthy aging promotion, and neurodegenerative disease treatment. These compounds stimulate telomerase expression and/or activity, leading to improved cellular health and function. In the environmental context, the compounds can be released in response to pollution levels exceeding a predetermined threshold, thereby mitigating the harmful effects of pollutants. In the health context, the compounds can be administered to individuals exposed to environmental toxins, radiation, or experiencing neurodegenerative diseases, to promote cellular health and function.

Novelty and Inventive Step

The new claims introduce a paradigm shift in the application of telomerase-activating compounds, moving from fertility to environmental sustainability and human health. The inventive step lies in recognizing the potential of these compounds to address critical issues in these new areas, and developing novel systems, methods, and compositions to achieve this.

Alternative Embodiments and Variations

Alternative embodiments include using different types of sensors or monitoring systems for pollution detection, or combining telomerase-activating compounds with other therapeutic agents for enhanced efficacy. Variations may include adjusting the dosage, administration route, or timing of compound delivery, or using different compounds with similar telomerase-activating properties.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the environmental and healthcare industries, with potential applications in pollution monitoring and control, cognitive health supplements, radiation protection products, healthy aging therapies, and neurodegenerative disease treatments. The target market includes companies, governments, and individuals seeking innovative solutions to pressing environmental and health concerns.

CPC Classifications

SectionClassGroup
A A61 A61K31/09
A A61 A61K31/137
A A61 A61K31/4025
A A61 A61K31/4545
A A61 A61K31/5377
A A61 A61K31/66
A A61 A61P15/08

Field of Art

Pharmaceutical biotechnology with a focus on cellular regeneration, telomerase modulation, and therapeutic compound development, involving expertise in molecular biology, pharmacology, and cellular biochemistry

Person of Ordinary Skill (PHOSITA) Profile

A researcher or scientist with advanced degrees in biochemistry or molecular biology, familiar with telomerase mechanisms, compound design, and therapeutic applications across multiple physiological domains

Obviousness Rationale

The PTD represents a predictable extension of the source patent's core technology by applying telomerase-activating compounds to additional physiological contexts. A PHOSITA would recognize that telomerase's cellular regenerative properties could be leveraged beyond fertility applications into broader health and environmental domains. The fundamental mechanism of telomerase activation remains consistent across these varied applications, suggesting an obvious technological progression.

Obvious Combinations & Variations

Source Patent Element
Telomerase-activating compounds for fertility enhancement
PTD Variation
Applying telomerase-activating compounds to environmental pollution monitoring and mitigation
Obviousness Reasoning
Known cellular regeneration mechanisms suggest predictable results when extending compound applications to stress response and cellular protection in different environmental contexts
Source Patent Element
Modulating cellular expression and tissue function through compound interactions
PTD Variation
Stimulating telomerase expression in neural tissues to address neurodegenerative conditions
Obviousness Reasoning
Established understanding of telomerase's cellular repair mechanisms makes neural tissue application a straightforward and predictable technological extension
Source Patent Element
Pharmaceutical compositions targeting specific cellular processes
PTD Variation
Developing radiation protection compositions combining telomerase-activating compounds with radioprotective agents
Obviousness Reasoning
Combination of known protective agents represents a standard design approach in pharmaceutical development, with predictable synergistic potential
Source Patent Element
Methods of contacting cells with telomerase-activating compounds
PTD Variation
Creating sensor-driven delivery systems for targeted compound release based on environmental or physiological conditions
Obviousness Reasoning
Adaptive drug delivery represents a known technological strategy, with sensor-based triggering being a predictable engineering solution
Source Patent Element
Cellular and tissue-level interventions for functional improvement
PTD Variation
Cognitive function enhancement through targeted telomerase activation in brain cells
Obviousness Reasoning
Extending cellular regeneration principles to neurological contexts represents a logical and foreseeable technological progression
35 U.S.C. § 103 Summary: Based on US Patent 11857516's disclosure of telomerase-activating compounds, the present publication demonstrates that a person having ordinary skill in the art would find the extended applications of such compounds to environmental monitoring, neural health, and radiation protection to be obvious variations. The consistent underlying mechanism of telomerase activation and cellular regeneration provides a clear technological foundation for these predictable extensions, thus rendering potential claims in these domains obvious and unpatentable.

Original Patent Information

Patent NumberUS 11,857,516
TitleTelomerase activating compounds for use in fertility and related applications
Assignee(s)Neuromagen Pharma, Ltd.